The MONITOR Ecosystem: A Digital Health Intervention for the Early Detection, Control, Follow-Up, and Management of COVID-19 in Mexico by Betancourt-Cravioto, Miguel et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







The MONITOR Ecosystem: A 
Digital Health Intervention for 
the Early Detection, Control, 
Follow-Up, and Management of 
COVID-19 in Mexico
Miguel Betancourt-Cravioto, Jorge Falcón-Lezama, 
Fernando Rojas-Estrella, Rodrigo Saucedo-Martínez  
and Roberto Tapia-Conyer
Abstract
In fighting infectious disease outbreaks, a basic epidemiological principle is to 
detect cases quickly and to isolate each case, to interrupt transmission. This principle 
has been the cornerstone of the Carso Group (CG) COVID Protocol, a systematic blue-
print for the reopening of operations of workplaces in the context of ongoing disease 
transmission in Mexico. The CG comprises over 50 companies with approximately 
180,000 employees engaged in economic activities including telecommunications, 
retail, construction, banking, mining, and manufacturing, among others. To cope 
with the COVID-19 pandemic within the CG, the Carlos Slim Foundation designed, 
developed and implemented MONITOR, a digital health ecosystem comprising a 
mobile phone application, web portal, and analytics platform, to assess the infec-
tion risk of each employee, follow-up their health status, and detect early symptoms 
of COVID-19. MONITOR provides daily notifications for any suspected cases and 
activates a COVID-19 testing request and follow-up of results. This intervention helps 
rapidly identify and isolate suspected cases, as well as follow-up of work and family 
contacts, to prevent further outbreaks. Use of MONITOR has thus enabled contain-
ment of COVID-19 in workplaces and safe return to work. MONITOR is an example of 
the implementation of public health practices in workplaces and can serve as the basis 
for larger deployment in population-wide settings.
Keywords: COVID-19, SARS-CoV-2, digital health, outbreak, prevention, pandemic, 
surveillance
1. The SARS-CoV-2 outbreak
A cluster of cases of pneumonia with unknown etiology was first reported in 
Wuhan, Hubei Province, China in December 2019. Subsequent analysis identi-
fied a novel coronavirus, later named severe acute respiratory syndrome coro-
navirus-2 (SARS-CoV-2). The disease caused by the virus was eventually called 
Viral Outbreaks
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coronavirus disease 2019 (COVID-19) [1, 2]. On January 30, 2020, the World 
Health Organization (WHO) declared the outbreak a Public Health Emergency of 
International Concern; on March 11, a pandemic was declared [3].
Coronaviruses are widely distributed globally [2]. Most human coronavirus 
infections are mild; however, two previous outbreaks led to many illnesses and 
deaths. The epidemics of severe acute respiratory syndrome coronavirus (SARS-
CoV) in 2002–2003 and Middle East respiratory syndrome coronavirus (MERS-
CoV) in 2012 resulted in many people developing severe pneumonia, with mortality 
rates of 10% and 36%, respectively [4].
According to the WHO, a patient with suspected COVID-19 infection is anyone 
meeting the clinical criteria with respect to signs and symptoms associated with 
the disease, including fever, dry cough, and fatigue. Other less common symptoms 
include myalgia, nasal congestion, headache, conjunctivitis, sore throat, diar-
rhea, and smell or taste disorders (anosmia and dysgeusia). Epidemiologic criteria 
include exposure to an area with a high risk of viral transmission or community 
transmission owing to work, residence, or travel [5].
COVID-19 infection exhibits different effects in different groups and individuals. 
Most infected people have mild- or moderate-intensity symptoms and approxi-
mately 80% recover without the need for hospitalization. One in five people develop 
severe illness and experience breathing difficulties, among other serious symptoms. 
Importantly, it is possible that transmission can occur from someone who either has 
mild symptoms, remains asymptomatic, or is in the incubation period [6].
According to the United States Centers for Disease Control and Prevention 
(CDC), the incubation period (time from infection to illness onset) is from 2 to 
14 days after exposure, and symptoms develop in 97.5% of infected individu-
als within 12 days [7]. Adopting a 14-day period of quarantine has become the 
standard procedure for individuals who have been in contact with someone with a 
confirmed COVID-19 diagnosis or who have traveled to high-risk areas [8].
SARS-CoV-2 is transmitted through droplets produced when an infected person 
coughs, sneezes or talks, which are ingested or inhaled by an individual nearby 
(within a distance of approximately 2 meters). A person can also become infected 
by touching a contaminated surface or object that has been contaminated with the 
virus and subsequently touching the mouth, nose, or eyes [9]. The diagnosis of 
COVID-19 is confirmed via a positive nucleic acid test result using sputum, a throat 
swab, or lower respiratory tract secretion sample [10].
The Lancet COVID-19 Commission has offered a list of practical solutions to the 
challenges during the current pandemic. One set of solutions is focused on nonphar-
maceutical interventions in which governments, non-governmental organizations 
(NGOs), and the private sector collaborate to mitigate negative consequences of the 
pandemic [11]. In line with this, the WHO has recommended the use of face masks, 
proper hand hygiene, physical distancing and mobility restrictions, among other 
measures [12–14]. In Mexico, the federal government announced the National Social 
Distancing Period Intervention, which included closure of non-essential public and 
private activities with the objective of reducing population mobility to limit com-
munity transmission, especially among those with a high risk of developing compli-
cations (age 60 years and older; people with hypertension, type 2 diabetes, obesity, 
respiratory diseases, or immunosuppression [15–17]; and pregnant women) [18].
2. About the Carso Group
The Carso Group (CG) is a Mexico-based conglomerate of companies spanning 
five sectors: commercial, infrastructure and construction, industrial, energy, and 
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banking [19]. CG comprises more than 50 companies, with operations in over 5000 
locations throughout Mexico and approximately 180,000 employees. CG companies 
are located in 1333 municipalities (54.2% of the total municipalities) within the 32 
Mexican states, and 83% of these are located in 20 metropolitan areas: 45.6% in the 
Mexico City Metropolitan Area, 4.1% in Puebla-Tlaxcala, 4.1% in Guadalajara, 3.9% 
in Tijuana, and 3.8% in Monterrey.
The COVID-19 pandemic has affected all economic activities globally, forcing gov-
ernments and entities to implement actions to contain its transmission [20–22]. Among 
the most important of these, most economic activity has shifted to telework, with the 
exception of activities that are deemed essential [12, 15, 23]. Importantly, some CG 
companies are engaged in essential economic activities in areas such as telecommunica-
tions, banking, mining, and energy. In addition, CG employees have varying levels 
of risk, either owing to older age or underlying non communicable diseases (NCDs). 
Some employees are more vulnerable because the nature of their work requires 
constant interaction with others, such as those working in retail stores, or because their 
household or workplace is located in a municipality with a high risk of contagion.
In response to the COVID-19 pandemic, the CG Board of Directors commis-
sioned the Carlos Slim Foundation (CSF), a non-profit independent organization 
linked with the Group, to design and implement a comprehensive response protocol 
to contain the spread of COVID-19 in the workplace, with the goal of protecting the 
health of employees and their families, as well as suppliers and clients.
The CSF was founded in 1986. Its aim is to address social inequalities by improv-
ing quality of life for the most vulnerable populations by training human resources 
and promoting greater opportunities. The scope of work of the CSF spans education, 
employment, health, nutrition, social justice, culture, human development, natural 
disaster support, economic development, and environmental protection [24].
The Carso COVID Protocol is the result of the abovementioned efforts. The 
protocol is divided into two components, launched at different times during the 
COVID-19 pandemic in Mexico; Annex 1 provides greater detail regarding the policies 
and recommendations outlined in the Protocol:
• Prevention and containment of COVID-19, launched on March 13, 2020
• Safe return to work, launched on May 22, 2020.
The CSF has extensive expertise in the design, development, implementation, and 
scale-up of digital health (DH)-based solutions aimed at improving health care service 
delivery to strengthen primary care, with a strong focus on prevention [25]. Hence, 
the CSF convened a team of experts in different disciplines to design a COVID-19 
digital health ecosystem to facilitate implementation of the Carso COVID Protocol.
3. Digital health in the response to viral outbreaks
One of the basic epidemiological principles in mitigating infectious disease out-
breaks is to stop transmission through timely detection and isolation of cases [26]. 
Hence, leveraging DH contributes to an effective public health strategy to prevent 
and mitigate the spread of an infectious disease [27].
DH is the new paradigm in health care, defined as “the convergence of four 
disruptive technologies: 1) the use of digital platforms, connected through 
micro-services, 2) cloud-based services with robust infrastructure to support 
big data transactions, 3) use of inter-connected wearables, devices and tracers, 
and 4) connecting communities through mobile phone apps and social media. 
Viral Outbreaks
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These technologies are enhanced by Artificial Intelligence.” [28]. The potential 
of DH has been demonstrated in detecting and mitigating infectious disease 
outbreaks and epidemics in countries worldwide [29]. Some examples of success-
ful DH-based strategies include the 2014–2016 Ebola outbreak across West Africa 
[27] and the 2003 global outbreak of SARS-CoV [29]. In Mexico, there is evidence 
of the benefits of a mobile phone-based intervention to support surveillance dur-
ing the H1N1 influenza pandemic in 2009 [30].
The current COVID-19 pandemic highlights the need for innovation in continu-
ous surveillance, rapid diagnosis, and real-time contact-tracing of emerging infec-
tious diseases. Health systems are structured around face-to-face medical visits, 
which involve direct interaction between patients and their health care providers 
[31]. This operating model can contribute to faster spread of infection among unin-
fected individuals, quickly overwhelming available critical care services [31, 32]. 
Additionally, health care providers are at high risk of exposure to COVID-19 infec-
tion, which leads to reduced availability of skilled clinicians over time. When health 
care resources are strained to a breaking point, patient care may be compromised, 
which is associated with negative outcomes and increased mortality rates [33].
Given the aforementioned scenario, there is a window of opportunity to imple-
ment, expand, and integrate DH technologies across the health care system [34]. The 
use of digital platforms has become the primary means of communication whereby 
people, governments, organizations, and health institutions can communicate, work, 
interact, share and exchange knowledge and information, and generate data [35].
DH has become increasingly instrumental in the response of governments and 
organizations to COVID-19 [36]. DH solutions include, but are not limited to, 
telemedicine/telehealth, electronic medical records, public health surveillance 
leveraging on big data and AI algorithms, wireless health sensors, georreference-
based tracing technologies, mobile health applications (apps), and health analyt-
ics platforms for public health and clinical decision-making [33]. In the case of 
COVID-19, DH can offer real-time access to comprehensive individualized reliable 
data, to enable personalized monitoring and provide AI-based assistance. DH can 
Type of solution Type of tool Country and developer
A. COVID-19 general information
Coronavirus symptoms Government websites, 
apps, chatbots, forums, 
SMS text messaging, call 
centers
WHO: Chatbot [38], website [39]
PAHO: Website [40]
Uruguay: Call center [41]
Paraguay: Ministry of Health free call center 
[42]
Mexico: COVID-19MX App [43], chatbot [44], 
websites [44–46]
Trinidad and Tobago: Website [47]
Argentina: Chatbot [48]
Jamaica: Website [49]
USA: CDC website [8]
Spain: Ministry of Health website [50] and 
AsistenciaCOVID19 App [51]
Canada: COVID-19 Virtual Assistant and 
website [52]
Colombia: Government website, telephone 
lines, and virtual assistant [53]
Bolivia: Government COVID-19 call center and 
BoliviaSegura App [54]
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Type of solution Type of tool Country and developer
Real-time information 





WHO: Interactive dashboard [55]
PAHO: Big data tool [56]
Google: COVID-19 Situation Dashboard [57]
Humanitarian response: Interactive map [58]
HealthMap: Interactive map [59]
Johns Hopkins: Interactive dashboard [60, 61]
Spain: Ministry of Health website [62]
Brazil: Ministry of Health Interactive map [63]
Mexico: COVID-19 Situation Dashboard 
UNAM [64] and COVID-19 Traffic Light 
Monitoring System SSA [65]
Jamaica: Interactive dashboard [66]




Government websites PAHO: COVID-19 website [68]
WHO: COVID-19 website [39]
Mexico: COVID-19 web page [44]
Spain: Ministry of Health website [62]
USA: CDC website [69] and Department of 
Health and Human Services [70]
Canada: COVID-19 website [71]
Colombia: Government website [53]
Bolivia: Government COVID-19 website [54]
Self-diagnosis
support to seek medical 
care
Apps, chatbots, 
websites, call centers, 
self-assessment tools
WHO: Chatbot [38]
Google: COVID-19 self-assessment [72]
Johns Hopkins: Coronavirus self-checker tool 
[73]
Peru: COVID-19 coronavirus evaluation
CDC: Coronavirus self-checker tool [74]
Jamaica: Call centers [75]
MAYO Clinic: Coronavirus self-assessment 
tool [76]
Canada: COVID-19 self-assessment tool [77]
Colombia: COVID-19 self-diagnosis tool [78] 
and virtual assistant [53]
USA: Veterans Crisis Line Veterans Health 
Administration - COVID-19 Response Plan 
[79]
General guidance
from health care 
professionals
Apps, call centers Argentina: National call center [80]
Uruguay: Chatbot and call center [81]
Mexico: National Call Center [82], UNAM call 
center [83]
B. Teleconsultation and patient monitoring
Patient monitoring and 
follow-up, contact tracing
Apps, call centers, 
teleconsultations
Brazil: Monitora COVID-19 App [84]
Uruguay: Coronavirus UY App [85]
France: StopCovid App [86]
China: Beijing Cares App [87]
Australia: COVIDSafe App [88]
South Korea: Self-quarantine Safety Protection 
App [89]
India: AarogyaSetu App [90]
USA: Veterans Health Administration - 
COVID-19 Response Plan [79]
Indonesia: PeduliLindungi App [86]
Germany: Corona-Datenspende [91] and 
Corona-Warn-App [86]




also be implemented to access reliable data and information, participate in social 
media, use risk-based algorithms to support self-diagnosis, seek health profession-
als to receive clinical support, and maintain work activities, among other applica-
tions [35, 37]. Table 1 shows some DH solutions that have been developed and are 
being used by institutions, governments, and NGOs around the world to prevent, 
manage, and mitigate COVID-19.
4. MONITOR digital health ecosystem
The first case of COVID-19 in Mexico was reported on February 27, 2020 
[108, 109]. Fully aware of the benefits of DH, the CSF had begun to work on the 
design of a robust response plan in January 2020. On March 13, 2020, the Carso 
COVID Protocol was launched, including a comprehensive set of actions and 
recommendations to prevent and contain COVID-19 in the workplace. As part of 
implementation of the Protocol, the CSF launched the MONITOR digital health 
ecosystem (MDHE), aimed at monitoring the wellbeing of CG employees and 
their families.1
MONITOR was initially designed based on WHO and CDC guidelines, and its 
recommendations are in compliance with current regulations of Mexico’s Ministry 
1 Annex 1 provides a detailed description of the recommendations and actions in the Carso COVID-19 
protocol.
Type of solution Type of tool Country and developer
Clinical support from 
health professionals
Apps, call centers, 
teleconsultations
Guatemala: Online doctor app [94]
Peru: Telephone line [95]
USA: Veterans Health Administration - 
COVID-19 Response Plan [79]
USA: Department of Health and Human 
Services [70]
Follow-up of suspected 
cases
in quarantine
Apps, call centers, 
teleconsultations
Brazil: Monitora COVID-19 App [84]
Colombia: CoronApp [93]
Costa Rica: EDUS COVID-19 app [96]





Mexico: phone line, WhatsApp for emotional, 
nutritional, and medical attention for TecSalud 
workers [97]








WHO: Virtual Health Library COVID-19 [98]
Cochrane Library on COVID-19 [99]
PubMed: LitCovid literature hub [100]
OAS: Organization of American States COVID-
19 Repository [101]







WHO: Virtual Campus [103]
PAHO: Virtual Campus [104]
Mexico: Mexican Government website COVID-
19 courses [105]
Coursera: Virtual Campus [106]
CDC: Virtual Campus [107]
Table 1. 
Digital solutions developed to prevent and manage COVID-19 around the world.
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of Health. Furthermore, MONITOR has been continuously updated with the latest 
available scientific evidence.
The MDHE comprises three interconnected platforms operating concurrently: 
a mobile phone application and a web portal for employees and their families to 
register and report symptoms on a daily basis, the Integrated Measurement for 
Early Detection (MIDO)-COVID Platform to assess NCDs and COVID-19 serologi-
cal status among employees at worksites, and the Health Intelligence Platform with 
robust analytics to support decision making. Importantly, the MDHE is compliant 
with Mexico’s regulatory standards in terms of confidentiality, security and privacy.
4.1 Prevention and containment of COVID-19 in the workplace
MONITOR enables the implementation of a COVID-19 prevention and contain-
ment strategy according to the following stepwise process:
1. An employee registers in MONITOR using either the mobile phone app or a 
secure web portal. During registration, the employee is asked to provide infor-
mation on any existing NCDs.
2. On a daily basis, individuals report whether they have any symptoms and if 
so, describe those symptoms. Using a point-based risk algorithm, MONITOR 
automatically assesses and classifies each person’s risk and provides immediate 
recommendations, as follows:
a. No risk (no symptoms): the employee is encouraged to continue notifying 
on a daily basis.
b. Mild risk: the employee is encouraged to increase the number of notifica-
tions to twice a day and to continue monitoring.
c. Moderate risk: the employee is encouraged to increase notifications to twice a 
day and if necessary, to call a dedicated call medical center operating 24/7/365.
d. Severe risk: the employee is encouraged to increase notifications to twice a 
day and to call a medical call center. In addition, an alert is triggered to the 
human resources (HR) department of the employee’s company, to signal a 
potential complication.
3. At the medical call center, a general physician provides remote counseling, and 
assesses whether the employee requires a reverse transcription polymerase 
chain reaction (RT-PCR) test to confirm a diagnosis of COVID-19 infection, or 
whether they need to be referred for immediate medical assessment.
4. If a person is referred for an RT-PCR test, the general physician schedules an ap-
pointment at any of the CG-dedicated lab facilities in Mexico City and 27 cities 
throughout the country. Once the employee has been tested, they are instructed 
to remain in isolation until their test results are obtained, within 24–48 hours.
5. Upon confirmation of COVID-19 infection:
a. The employee receives a pulse oximeter for self-monitoring during the 




b. The CSF epidemiology team, in coordination with company HR depart-
ments, conducts an outbreak investigation for each employee with 
confirmed COVID-19 infection, including tracing of all work and family 
contacts. A contact is defined as someone who has remained in close prox-
imity (less than 2-meter distance) with the employee for at least 15 minutes 
while not wearing personal protective equipment; this definition is in line 
with WHO recommendations [9, 10].
c. All identified contacts are sent for confirmatory laboratory testing and are 
closely monitored throughout the period in which they are ill.
6. All collected data are available through the Health Intelligence Platform for 
real-time analytics, follow-up, and clinical support, for both HR departments 
and the CSF epidemiology team.
4.2 Safe return to work with MIDO-COVID
With ongoing transmission of SARS-CoV-2 during the phased reopening of non-
essential activities in Mexico, a series of measures were implemented in CG’s work-
places to ensure the safe return of employees. These measures are described in Annex 1.
There is ample scientific evidence demonstrating that the presence of comor-
bidities increase the risk of severity and complications of COVID-19, particularly 
cardiovascular disease, diabetes, hypertension, chronic lung or renal disease, 
and obesity [17]. In light of this evidence and building on previous experience 
[110–112], the CSF designed and developed the MIDO-COVID Digital Platform, 
aimed at assessing NCDs and COVID-19 serological status among employees 
resuming operations in the workplace.
Like MONITOR, MIDO-COVID is implemented following a stepwise process, 
performed by a MIDO expert2:
1. Registration of employees in MIDO-COVID, retrieving their data from the 
MDHE.
2. Measurement of weight/waist circumference and height, blood pressure, and 
capillary blood glucose, either fasting or random.
3. Performance of rapid antibody tests.
4. Recording of measurements and serologic test results.
5. Analytical algorithm with integrated risk profiling:
a. NCDs profile with interpretation and recommendations.
b. Serology test results with interpretation and recommendations.
The MIDO-COVID Digital Platform automatically delivers certified serologic 
test results. Importantly, this assessment confirms the presence of NCDs and 
2 In each workplace, employees are chosen to be trained as MIDO-COVID experts. These employees 
complete an online course in which they learn to measure weight, height, blood pressure, and capillary 
blood glucose; and how to record these measurements in the digital platform, perform serological tests, 
and provide brief counseling when informing employees of their test results.
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validates the self-reports provided by employees using the mobile phone app. 
Finally, in the case of active COVID-19 infection, the employee is quarantined and 
the contact tracing protocol is begun, as described above.
In sum, joint coordination of the HR department at each company with the 
epidemiology team at the CSF has enabled effective deployment of the Carso 
COVID Protocol through the use of MONITOR. Table 2 shows the main results of 
the MDHE as of October 31, 2020.
5. Permanent strategies following the current public health emergency
Given that the COVID-19 pandemic has changed the way that companies 
function, the CG intends to retain certain strategies to protect employees’ health. 
The COVID-19 pandemic has provided an excellent opportunity to improve the 
workplace environment in terms of health and safety at every worksite. The CG 
is fully committed to providing every employee with all the preventive tools, 
measures, and strategies needed to maintain a physically and mentally healthy 
community. In this sense, the CSF encourages joining MONITOR together with 
MIDO, with the recognition that poor control of NCDs increases the risk for 
COVID-19 complications [113]. MIDO screening can facilitate early detection of 
type 2 diabetes, hypertension, and dyslipidemia, focusing specifically on pre-
disease stages and early treatment. MIDO offers a systematic risk assessment of 
screened individuals, identifying those with a healthy, at-risk (pre-disease), or 
disease status [112].
Inter-connecting MONITOR and MIDO-COVID in a digital ecosystem allows 
HR personnel to identify COVID-19 positive employees or those with high-risk of 
complications. Daily information can be used to better monitor, diagnose, track 
and control employees’ infection risk and overall health. Moreover, data are stored 
in a secure cloud, where it can be retrieved to generate predictive models for each 
Registrants in MONITOR N = 254,043
Employees 184,117
Family relatives 69,926
1. Prevention and containment of COVID-19 in workplaces
Medical call center calls 257,803
Laboratory tests performed 29,693
Positive cases (positivity rate) 5124 (17.2%)
Outbreak studies in workplaces 1840
2. Safe return to work with MIDO-COVID
Total assessments 46,740
Main results of serology tests
IgM − / IgG – (not exposed) 39,505 (84.5%)
IgM + / IgG – (early-stage infection) 322 (0.7%)
IgM + / IgG + (acute infection) 2013 (4.3%)
IgM − / IgG + (past infection) 4812 (10.3%)
Table 2. 
Main results of the MONITOR digital health ecosystem (13 march to 31 October, 2020).
Viral Outbreaks
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company and type of workplace, as a strategy to better understand and control risk 
factors in each sector.
Flexible schedules, in which employees alternate teleworking and working at a 
CG location when necessary, are very important. If an employee feels unwell, they 
must notify their direct manager and should not present to their work location. In 
worksite dining rooms, menus should be based on nutritional recommendations 
following the EAT-LANCET Commission on healthy diets and sustainable food 
production. Every meal is to be prepared according to the planetary health plate, 
characterized by at least 50% vegetables (fruits and vegetables) and the remainder 
comprising whole grains, plant-source protein, animal-source protein, dairy foods, 
and unsaturated plant oils [114].
Workplaces are implementing programs to promote wellbeing and healthy 
lifestyles among employees and their household members. In this way, the CG 
seeks to empower its employees through health promotion initiatives conducted 
by trained multidisciplinary health professionals in topics including nutrition, 
NCDs prevention, physical activity, vaccination, mental health awareness, and 
wellbeing.
As part of its response to COVID-19 as well as other novel pathogens, the CG 
plans to create emergency response teams and permanent communication via DH 
among HR departments across all CG businesses. Frequent intervention assess-
ments will be carried out to gauge adherence to protocols and determine where 
improvements are needed.
6. Conclusions
This chapter describes the CG COVID-19 mitigation strategy within a corporate 
group in Mexico. Priorities for the CG during this outbreak have been to protect 
employees’ health and wellbeing by implementing protocols and strategies based 
on scientific evidence. Consequently, occupational safety and health have taken on 
greater relevance in all kinds of workplaces.
First, our experience shows that Digital Health can be used to quickly 
identify people with any infection risk, during early stages. CG employees 
are empowered through advice and counseling using IT tools such as a mobile 
phone app or website. The MONITOR strategy has proven to be an effective 
intervention. The use of DH has been instrumental in outbreak control and 
maintaining workplace activities. Second, we have learned that the use of a 
Digital Health ecosystem is effective in detecting and controlling COVID-19 
outbreaks in work settings.
This experience can be useful for other organizations in the process of implement-
ing and operating digital health based strategies to cope with outbreaks of viral disease.
Acknowledgements
We wish to acknowledge the work of the different HR departments of CG in 
the implementation and follow-up of the Carso COVID Protocol. The strategy and 
results included in this chapter were only possible because of their dedication, and 
their hard work.
On the other hand, we acknowledge the help provided by Alejandra Cantoral, 
ScD., Larissa Betanzos, ScM, and Adriana Granich, MD, for the data compilation 
of digital health solutions around the world. We also acknowledge Analisa Avila, of 
Edanz Evidence Generation, for editorial support.
11
The MONITOR Ecosystem: A Digital Health Intervention for the Early Detection, Control…
DOI: http://dx.doi.org/10.5772/intechopen.95260
Conflict of interest





CDC Centers for Disease Control and Prevention
CG Carso Group
CSF Carlos Slim Foundation
DH digital health
HR human resources
MDHE MONITOR digital health ecosystem
MERS-CoV Middle East respiratory syndrome coronavirus
MIDO Integrated Measurement for Early Detection
NCDs non-communicable diseases
NGO non-governmental organization
PAHO Pan American Health Organization
RT-PCR reverse transcription polymerase chain reaction
SARS-CoV severe acute respiratory syndrome coronavirus
SARS-CoV-2 severe acute respiratory syndrome coronavirus-2
SSA Ministry of Health
WHO World Health Organization
Appendix 1. The Carso COVID Protocol
To support the Carso Group (CG) COVID-19 response plan, the Carlos 
Slim Foundation prepared and designed the Carso COVID Protocol, called the 
“Recommendations and guidelines for the prevention and management of COVID-
19 in an organization”. The Protocol has two components, launched at two time 
points during the course of the pandemic:
• Prevention and containment of COVID-19, launched on March 13, 2020 
(Supplementary Table 1)
• Safe return to work, launched on May 22, 2020 (Supplementary Table 2).
This Protocol is based on scientific evidence regarding infectious diseases and 
the most important available evidence regarding COVID-19 to date. Most recom-
mendations are based on WHO and CDC guidelines and are continuously updated 
as new evidence becomes available.
The Protocol was designed with consideration for the needs of the different CG 
workplaces. Nonetheless, each company within the CG has adapted the recommen-
dations to the operational needs of each workplace. For example, most employees 
in workplace settings that were not considered essential switched to teleworking 
whereas employees performing activities classified as essential implemented differ-
ent schemes, such as staggered working schedules. It is noteworthy that the Protocol 
was implemented at all CG worksites.
Viral Outbreaks
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In each company, this 
refers to a team comprising 
employees with decision-
making capacity.




operations policies and 
guidelines.
• Oversee adequate implementation of the COVID-19 
protocol.
• Communicate general preventive measures.
• Ensure the implementation of proper cleaning and 
disinfection policies.
• Define and implement work-at-home policies and 
provide guidance to staff regarding their implemen-
tation to maintain operations.
• Monitor employees’ health status and implement 
quarantine and isolation policies according to 
guidelines.
• Monitor the evolution of employees with COVID-19 
infection in isolation.
• Update COVID-19 prevention and care policies 




Identifying the point of 
contact in each workplace 
and department to 
communicate new policies 
and guidelines.
• Communication of Protocol policies through 
available channels: billboards, intranet, email, social 
media, mobile phone text messaging, etc.
• Implementation of a “hotline” available to employees 




This refers to general 
containment measures for 
employees.
Measures are classified according to risk:
• General (employees, suppliers & visitors).
• Asymptomatic employees.
• Employees with any symptoms of respiratory 
infection.
• Employees diagnosed with COVID-19 (suspected 





This describes hygiene 
and physical distancing 
measures that must be 
implemented in each 
workplace.
The supplies needed to 
implement these policies 
are also listed.
Recommendations for 
working from home are 
given.
• Placement of posters and communication materials.
• Availability of face masks at workplaces, as well as 
bins for their disposal.
• Equipment for cleaning staff.
• Use of 0.1% chlorine solution or 70% ethanol for 
disinfection of surfaces.
• Handwashing and use of alcohol-based hand 
sanitizer.
• Suspension of air conditioner use and proper ventila-
tion measures.
• Physical distancing.
• Staggered work schedules in confined or crowded 
workspaces.
• Working from home.
• Recommendations for vulnerable populations
• Timely notification of symptoms.
• Establishment of a COVID-19 team in each 
workplace.
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measures that dining room 
staff must implement 
during the preparation of 
meals and cleaning of the 
dining room.
• Measures at the dining room entrance and restriction 
of access for employees who do not comply with 
policies.
• Use of personal protective equipment among dining 
room staff.
• Safe use of trays, glasses, and cups.
• Elimination of self-service areas, such as salad bars 
or shared condiments.




Describes policies and 
guidelines that all cleaning 
staff must comply with.
• Policies for work attendance.
• Use of uniforms and restrictions regarding jewelry 
and beards.
• Use of personal protective equipment.
• Use of 0.1% chlorine solution or 70% ethanol to 
disinfect surfaces.
• Suspension of air conditioner use and proper ventila-
tion measures.




Describes general policies 
for travel, meetings, and 
events.
This section emphasizes 
the importance of 
transitioning to tele- or 
video conferences.
• Cancelation or restriction of national and interna-
tional travel.
• Isolation policies after returning from essential 
travel.
• Suspension of conferences, events, or summits, 
regardless of their nature.
• Restriction of visitors and suppliers in the workplace.
• Promotion of tele- and video conferences.




This section describes 
the general policies for 
workplaces that provide 
customer service, such 
as retail and post-sales 
services and banking.
• Use of face masks and personal protective 
equipment.
• Cleaning of workspaces, and use of 0.1% chlorine 
solution or 70% ethanol for disinfection.
• Identification and management of suspected cases of 
COVID-19 infection.
Call centers • Alternating work shifts to facilitate physical 
distancing.
• Identification and management of suspected cases of 
COVID-19 infection.
• Use of 0.1% chlorine solution or 70% ethanol to 
disinfect surfaces.
Table S1. 







• Reinforcement of basic preventive measures.
• Adaptation of workspaces:
 ○ Screens and partitions between workstations.
 ○ Signs outlining requirements and recommendations posted in areas with high 
visibility.
 ○ Strategically located alcohol-based hand sanitizer dispensers that are 
constantly stocked.




• Staggered work shifts and working from home.
• Implementation of flexible work schedules.
• Restrictions in common areas, e.g., dining rooms, hallways, and reception desks.
• Protocols for interaction with suppliers and customers.
• Restriction of meetings and promotion of tele- and video conferences.
Measures to 
reduce risk of 
infection
• Organization of teams to supervise the correct application of basic preventive 
measures.
• Point-of-entry screening in each workplace.





• Permanent social media campaigns to raise awareness.
• Development and adaptation of content and materials: the CSF developed a web 
portal with curated information about COVID-19. As of October 31, the CSF 
has produced more than 150 informational materials including infographics, 
videos, and audio recordings to support CG companies in raising awareness about 
COVID-19.
• Two online courses for COVID-19 teams and employees
Table S2.. 
Supplementary Table 2. Safe return to work (summary).
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